BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Xellia Pharmaceuticals Expands Croatian Product And Innovation R&D Center Of Excellence With Investment Of US$2.0 Million

  May 14, 2014

   · 

  4 min read
• Biotech Bay

  OncoMed Pharmaceuticals, Inc. To Present Data From Three Clinical Studies At The 2014 American Society of Clinical Oncology Annual Meeting

  May 14, 2014

   · 

  14 min read
• Drug Development

  ChromaDex, Inc. Initiates Second Human Clinical Study For Its Caffeine Ingredient, PURENERGY®

  May 14, 2014

   · 

  5 min read
• Roche To Present New Data On 27 Different Medicines At American Society of Clinical Oncology

  May 14, 2014

   · 

  3 min read
• Business

  MRC Technology And Daiichi Sankyo, Inc. Collaborate To Identify Novel Targets For Drug Discovery

  May 14, 2014

   · 

  2 min read
• Biotech Bay

  Portola Pharmaceuticals, Inc. Announces Two Presentations Of Data On Cerdulatinib, An Oral Dual Syk/JAK Inhibitor, At 2014 American Society of Clinical Oncology Annual Meeting

  May 14, 2014

   · 

  7 min read
• Pharm Country

  BiologicTx Announces Initiation Of Observational Clinical Study For Regional Kidney Paired Donation Using Desensitization

  May 14, 2014

   · 

  2 min read
• Pharm Country

  Arno Therapeutics To Outline Two Phase I Studies Evaluating Onapristone In Men’s And Women’s Cancers At 2014 American Society of Clinical Oncology Annual Meeting

  May 14, 2014

   · 

  9 min read
• Biscayne Pharmaceuticals’ GHRH Technology Featured In Presentations At International Society For Heart Research Meeting

  May 14, 2014

   · 

  3 min read
• Negative National Institute for Clinical Excellence (NICE) Draft Guidance On Janssen Biotech Inc.'s Zytiga For Prostate Cancer

  May 14, 2014

   · 

  5 min read